Nuveen Asset Management’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-8,164
| Closed | -$1.01M | – | 3441 |
|
|
2021
Q1 | $1.01M | Sell |
8,164
-403
| -5% | -$49.7K | ﹤0.01% | 2881 |
|
|
2020
Q4 | $975K | Buy |
8,567
+106
| +1% | +$12.1K | ﹤0.01% | 2818 |
|
|
2020
Q3 | $1.01M | Buy |
8,461
+2,298
| +37% | +$275K | ﹤0.01% | 2684 |
|
|
2020
Q2 | $15.6M | Buy |
6,163
+4,300
| +231% | +$10.9M | 0.01% | 1195 |
|
|
2020
Q1 | $360K | Buy |
1,863
+1,452
| +353% | +$281K | ﹤0.01% | 2877 |
|
|
2019
Q4 | $137K | Sell |
411
-332
| -45% | -$111K | ﹤0.01% | 3105 |
|
|
2019
Q3 | $240K | Buy |
743
+15
| +2% | +$4.85K | ﹤0.01% | 3089 |
|
|
2019
Q2 | $314K | Buy |
+728
| New | +$314K | ﹤0.01% | 3098 |
|